Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
EARLY_PHASE1
INTERVENTIONAL
2018-01-24
2018-11-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Parkinson s disease (PD) is a neurologic disorder that causes slowness, tremor, rigidity, and imbalance. Gait impairment is also common. There are 2 substudies: (1) Physiology of Freezing and Gait; (2) Vibratory Cueing. Healthy participants can join only Substudy 1.
Objective:
To study gait disorders in PD. Also, to test the effect of specific interventions for gait in people with PD.
Eligibility:
People ages 18 and older who:
Have PD with bilateral symptoms but can walk without a cane or walker
Are healthy
Design:
Participants will be screened in Protocols 93-N-0202 and 01-N-0206.
Both substudies include a physical exam and medical history.
Substudy 1:
Participants will have one 6-hour visit. They must wear a tank tops and shorts with tennis shoes during the visit. They will perform gait tasks. Markers placed on the skin will record movements. They will have an EEG: They will wear an electrode cap to record brain waves. They will wear special glasses to record eye movements. Participants with PD will hold their morning dose of PD drugs. They can choose to be admitted to the hospital the previous evening. Otherwise someone else or a taxi must bring them to the visit. They will first perform the study tasks off their drugs. Then they will take their drugs and repeat them.
Substudy 2:
Participants will have one 3-hour visit. A small vibratory device will be attached to their ankle. Reflective markers placed on the skin will record movements while they walk:
Without the device
With the device, but the vibrator off
With the device, with the vibrator on
With a magnet attached to the ankle
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SCH: Context-aware Freezing of Gait Mitigation in Real-world Setting
NCT04746846
The Electrophysiological Investigation of Higher Level Neural Manifestations of Freezing of Gait in Parkinson's Disease Patient
NCT02214251
Vestibulopathy, Imbalance, and Gait Disturbances in Parkinson Disease
NCT05446194
Overcoming Gait Freeze in Parkinson's Disease Using Responsive Cueing
NCT05019469
External vs Internal-triggered Augmented-reality Visual Cues to Treat Freezing of Gait
NCT05608915
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Sub Study 1: Physiology of Freezing of Gait in Parkinson Disease (abbrev: Physiology of FOG)
1. Objective: To explore temporospatial gait parameters and joint kinematic patterns in patients with Parkinson disease and freezing of gait. In addition, tracking of eye movements and EEG patterns will also be studied in patients with Parkinson disease and freezing of gait.
2. Study Population: 15 PD patients with freezing of gait, 15 patients without freezing of gait, 15 age and gender matched healthy volunteers
3. Design: Prospective Exploratory study
4. Outcome Measures: Phase variability and coherence of oscillating axial and appendicular components of gait in patients with PD and freezing of gait, visual gaze fixations and saccades during freezing or freezing-like events and when approaching a variable width doorway, EEG patterns during an episode of freezing of gait or freeze-like event. The study will also aim to look at the difference in the phenomenon of FOG in OFF and ON states.
2. Sub Study 2: Effects of Rhythmic Vibratory Cueing to Improve Step Parameters in Parkinson Disease (abbrev. Vibratory Cueing)
1. Objective: To study changes in gait variables of patients with PD by providing rhythmic vibratory stimuli at the ankle on one limb at preset parameters.
2. Study population: 15 patients diagnosed as having Parkinson s Disease, Hoehn and Yahr stage 2-3.
3. Design: Prospective interventional hypothesis testing study. We will evaluate the effects of rhythmic vibratory cueing on gait variables in PD. The effects of vibratory cueing will be tested compared to baseline gait variables and with the use of a magnet (which will be the open label placebo intervention to account to some extent, for the open label design).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PD patients no
PD patients without freezing of gait
Mobile Gait Trainer
standard rolling walker that has a battery operated sensor attached to the side, designed to detect footsteps
Healthy
HV using Mobile Gait Trainer
Mobile Gait Trainer
standard rolling walker that has a battery operated sensor attached to the side, designed to detect footsteps
PD patients
pd patients using vibratory cueing device
vibratory cueing device
ankle brace with vibrator that provides electric stimulus
PD patients 1
PD patients with freezing of gait
vibratory cueing device
ankle brace with vibrator that provides electric stimulus
Healthy Volunteers
Age and gender matched healthy volunteers.
Mobile Gait Trainer
standard rolling walker that has a battery operated sensor attached to the side, designed to detect footsteps
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vibratory cueing device
ankle brace with vibrator that provides electric stimulus
Mobile Gait Trainer
standard rolling walker that has a battery operated sensor attached to the side, designed to detect footsteps
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to provide informed consent
* Clinical diagnosis of Parkinson disease by U.K. Parkinson Society Brain Bank Criteria
* Patients must be stage II -III on the Hoehn and Yahr scale
Exclusion Criteria
* Uncontrolled medical condition requiring immediate treatment that would make a walking trial unsafe for the subject.
* Peripheral neuropathy that severely limits gait
* Current or recent orthopedic disorder that severely limits gait
* Current uncontrolled depression or major depressive episode
* Gait disorders other than PD.
* Cannot walk safely without corrective lenses and without support.
* Unable to abstain from PD medications overnight for at least 12 hours before testing
* History of deep brain stimulation surgery
* Subjects who are NINDS employees
* In addition to the preceding criteria, healthy volunteers must also have a normal neurological examination performed within the last year. Healthy volunteers will be healthy subjects without any major medical and neurological or psychiatric disorders established by history and physical/neurological examination. They will also have no gait disorders from any medical or surgical problems as per clinical assessment.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shabbir Hussain I Merchant, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute of Neurological Disorders and Stroke (NINDS)
References
Explore related publications, articles, or registry entries linked to this study.
Kelly VE, Eusterbrock AJ, Shumway-Cook A. The effects of instructions on dual-task walking and cognitive task performance in people with Parkinson's disease. Parkinsons Dis. 2012;2012:671261. doi: 10.1155/2012/671261. Epub 2012 Dec 29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-N-0050
Identifier Type: -
Identifier Source: secondary_id
180050
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.